Patents by Inventor Jiro Hirose

Jiro Hirose has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Soluble CD14 antigen
    Patent number: 8124722
    Abstract: There are provided a soluble CD14 antigen which is a novel in vivo protein useful as a marker for diagnosing sepsis and has the following characteristic features 1) to 3): 1) a molecular weight of 13±2 kDa when measured by SDS-PAGE under non-reducing conditions; 2) an amino acid sequence in which the amino acid sequence of SEQ ID NO:1 is present on its N terminal; and 3) ability to specifically bind to an antibody prepared by using a peptide comprising 16 amino acid residues described in SEQ ID NO:2 for the antigen; and a recombinant soluble CD14 fragment.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: February 28, 2012
    Assignee: Mochida Pharmaceutical Co., Ltd.
    Inventors: Shoji Furusako, Kamon Shirakawa, Jiro Hirose
  • Soluble CD14 antigen
    Patent number: 7608684
    Abstract: There are provided a soluble CD14 antigen which is a novel in vivo protein useful as a marker for diagnosing sepsis and has the following characteristic features 1) to 3): 1) a molecular weight of 13±2 kDa when measured by SDS-PAGE under non-reducing conditions; 2) an amino acid sequence in which the amino acid sequence of SEQ ID NO:1 is present on its N terminal; and 3) ability to specifically bind to an antibody prepared by using a peptide comprising 16 amino acid residues described in SEQ ID NO:2 for the antigen; and a recombinant soluble CD14 fragment.
    Type: Grant
    Filed: May 11, 2005
    Date of Patent: October 27, 2009
    Assignee: Mochida Pharmaceuticals Co., Ltd.
    Inventors: Shoji Furusako, Kamon Shirakawa, Jiro Hirose
  • NOVEL SOLUBLE CD14 ANTIGEN
    Publication number: 20090203052
    Abstract: There are provided a soluble CD14 antigen which is a novel in vivo protein useful as a marker for diagnosing sepsis and has the following characteristic features 1) to 3): 1) a molecular weight of 13±2 kDa when measured by SDS-PAGE under non-reducing conditions; 2) an amino acid sequence in which the amino acid sequence of SEQ ID NO:1 is present on its N terminal; and 3) ability to specifically bind to an antibody prepared by using a peptide comprising 16 amino acid residues described in SEQ ID NO:2 for the antigen; and a recombinant soluble CD14 fragment.
    Type: Application
    Filed: February 27, 2009
    Publication date: August 13, 2009
    Inventors: Shoji FURUSAKO, Kamon Shirakawa, Jiro Hirose
  • Novel soluble CD14 antigen
    Publication number: 20060068445
    Abstract: There are provided a soluble CD14 antigen which is a novel in vivo protein useful as a marker for diagnosing sepsis and has the following characteristic features 1) to 3): 1) a molecular weight of 13±2 kDa when measured by SDS-PAGE under non-reducing conditions; 2) an amino acid sequence in which the amino acid sequence of SEQ ID NO:1 is present on its N terminal; and 3) ability to specifically bind to an antibody prepared by using a peptide comprising 16 amino acid residues described in SEQ ID NO:2 for the antigen; and a recombinant soluble CD14 fragment.
    Type: Application
    Filed: May 11, 2005
    Publication date: March 30, 2006
    Applicant: MOCHIDA PHARMACEUTICAL CO., LTD.
    Inventors: Shoji Furusako, Kamon Shirakawa, Jiro Hirose